BostonGene Receives Frost & Sullivan’s 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development…
